Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Brain plaques in healthy individuals linked to increased Alzheimer's risk

15.12.2009
Scientists have long assumed that amyloid brain plaques found in autopsies of Alzheimer's patients are harmful and cause Alzheimer's disease. But autopsies of people with no signs of mental impairment have also revealed brain plaques, challenging this theory.

Now, for the first time, researchers at Washington University in St. Louis have shown that brain plaques in apparently healthy individuals are associated with increased risk of diagnosis with Alzheimer's disease years later.

In two studies published this month in Archives of Neurology, scientists report that volunteers with brain plaques were more likely to have declining scores on annual cognitive tests, to show signs of shrinkage in a key brain area affected by Alzheimer's and to eventually be diagnosed with the disease.

"We don't have enough data yet to definitively say that people who scan positive for these brain plaques have presymptomatic Alzheimer's disease, but something is clearly going on that does not bode well for the health of their aging brains," says John C. Morris, the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology and director of Washington University's Alzheimer's Disease Research Center (ADRC) and the Friedman Center for Aging.

Morris and others at the ADRC have previously found evidence that Alzheimer's disease harms the brain for years prior to typical diagnosis. They are pushing for earlier diagnosis as an essential step to successful treatment of Alzheimer's disease, but to do that they first have to seek earlier indicators of disease and then wait years to see if people with the indicators later develop symptomatic Alzheimer's.

According to Morris, the new papers are early and encouraging indicators that scientists are on track to pushing back the time at which diagnosis can be made.

"We only have a very small number of subjects to date, but what we're learning so far has been consistent with our predictions," he says.

The new studies were made possible by the development of an imaging agent, Pittsburgh Compound B (PiB), that lets scientists use positron emission tomography scans to detect amyloid plaques in living brains for the first time. Prior to PiB, clinicians could only verify the presence of brain plaques during autopsies. PiB scanning of ADRC research participants is directed by Mark Mintun, M.D., vice chair for research in radiology and professor of radiology at the University's Mallinckrodt Institute of Radiology.

Martha Storandt, Ph.D., professor of psychology and of neurology, led one of the studies, which compared a variety of factors in plaque-positive and plaque-negative subjects.

"One of the main things we wanted to know was whether people who scanned positive for brain plaques scored abnormally low on cognitive tests," she says. "They didn't, but when we looked at their annual testing records over a period of years, we saw that the scores of the plaque-positive group were declining, while those of the plaque-negative group were not."

Magnetic resonance imaging scans analyzed by Denise Head, Ph.D., assistant professor of psychology, revealed that brain areas hit hard by Alzheimer's disease, such as the parahippocampal gyrus, were smaller in subjects with plaques.

In a second study, led by Morris, researchers tracked a group of 159 volunteers, ages 51 to 88, who were scanned using PiB between 2004 and 2008. At the time of the scans, none of the participants showed signs of mental impairment. Twenty-three of the volunteers later developed mild impairment, and nine members of that group were diagnosed with Alzheimer's disease.

Those who stayed mentally healthy did not scan positive for plaques, but volunteers later diagnosed with problems did. Comparisons of the volumes of key brain structures revealed the same disparities seen in the other study: subjects who developed mental impairment had significant reductions in their parahippocampal gyrus and other structures affected by Alzheimer's.

According to Morris, a parallel effort at Washington University that analyzes cerebrospinal fluid to diagnose Alzheimer's earlier is also meeting with early success. That program is led by David Holtzman, M.D., the Andrew and Gretchen Jones Professor and chair of the Department of Neurology and Anne Fagan, Ph.D., research associate professor of neurology.

Morris speculates that earlier diagnosis and testing of new treatments may be possible within the next 10 years.

"There are risks inherent in Alzheimer's treatments, so we have to be careful that healthy people who are selected to receive these treatments to prevent dementia caused by Alzheimer's disease really do have presymptomatic disease," he says.

Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA. Pittsburgh Compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer's disease. Archives of Neurology, Dec. 14, 2009.

Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss are signatures of cerebral amyloid beta deposition identified with PiB. Archives of Neurology, Dec. 14, 2009.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Michael C. Purdy | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>